Search

Your search keyword '"Ximénez-Carrillo Rico Á"' showing total 13 results
Start Over Author "Ximénez-Carrillo Rico Á"
13 results on '"Ximénez-Carrillo Rico Á"'

1. Prognostic factors and analysis of mortality due to brain haemorrhages associated with vitamin K antagonist oral anticoagulants. Results from the TAC Registry

Author

Zapata-Wainberg, G., Quintas, S., Ximénez-Carrillo Rico, A., Benavente Fernández, L., Masjuan Vallejo, J., Gállego Culleré, J., Freijó Guerrero, M. del M., Egido, J., Gómez Sánchez, J.C., Martínez Domeño, A., Purroy, F., Vives Pastor, B., Rodríguez Yáñez, M., and Vivancos, J.

Published
2018
Full Text
View/download PDF

2. Factores pronósticos y análisis de la mortalidad de las hemorragias cerebrales asociadas a anticoagulantes orales antagonistas de la vitamina K. Resultados del Estudio TAC Registry

Author

Zapata-Wainberg, G., Quintas, S., Ximénez-Carrillo Rico, A., Benavente Fernández, L., Masjuan Vallejo, J., Gállego Culleré, J., Freijó Guerrero, M. del M., Egido, J., Gómez Sánchez, J.C., Martínez Domeño, A., Purroy, F., Vives Pastor, B., Rodríguez Yáñez, M., and Vivancos, J.

Published
2018
Full Text
View/download PDF

3. Use of healthcare resources and costs of acute cardioembolic stroke management in the Region of Madrid: The CODICE Study

Author

de Andrés-Nogales, F., Vivancos Mora, J., Barriga Hernández, F.J., Díaz Otero, F., Izquierdo Esteban, L., Ortega-Casarrubios, M.Á., Castillo Moreno, L., Ximénez-Carrillo Rico, Á., Martín Torres, M.P., Gómez-Escalonilla Escobar, C.I., Torres González, C., de Salas-Cansado, M., Casado Gómez, M.Á., Soto Álvarez, J., and Gil-Núñez, A.

Published
2015
Full Text
View/download PDF

4. Utilización de recursos sanitarios y costes asociados al manejo de los pacientes con infarto cerebral cardioembólico agudo en la Comunidad de Madrid: Estudio CODICE

Author

de Andrés-Nogales, F., Vivancos Mora, J., Barriga Hernández, F.J., Díaz Otero, F., Izquierdo Esteban, L., Ortega-Casarrubios, M.Á., Castillo Moreno, L., Ximénez-Carrillo Rico, Á., Martín Torres, M.P., Gómez-Escalonilla Escobar, C.I., Torres González, C., de Salas-Cansado, M., Casado Gómez, M.Á., Soto Álvarez, J., and Gil-Núñez, A.

Published
2015
Full Text
View/download PDF

6. 20803. INFLUENCIA DE LOS FACTORES SOCIALES Y DEMOGRÁFICOS EN LOS TIEMPOS DE ATENCIÓN AL CÓDIGO ICTUS: ANÁLISIS MULTIDIMENSIONAL DE 131 BARRIOS DE UN NÚCLEO URBANO

Author

Alonso Castillo, R., Riera López, N., Lorente Moro, A., de Celis Ruiz, E., Higuera Ruiz de la Hermosa, A., Lorenzo Diéguez, M., Alonso de Leciñana Cases, M., Gómez-Escalonilla Escobar, C., Estebas Armas, C., Hervás Testal, C., Rigual Bobillo, R., Casado Fernández, L., González Martín, L., Ruiz Ares, A., Calleja Castaño, P., García Pastor, A., García Torres, A., Cruz Culebras, A., Ximénez-Carrillo Rico, Á., Rodríguez Rodil, N., Martínez Gómez, J., Fuentes Gimeno, B., and Rodríguez-Pardo de Donlebún, J.

Published
2024
Full Text
View/download PDF

7. 21004. UTILIDAD DE LOS VEHÍCULOS DE INTERVENCIÓN RÁPIDA VS. UVIS MÓVILES EN LA ATENCIÓN AL ICTUS AGUDO

Author

Higuera Ruiz de la Hermosa, A., Riera López, N., Lorente Moro, A., de Celis Ruiz, E., Alonso Castillo, R., Lorenzo Diéguez, M., Alonso de Leciñana, M., Gómez-Escalonilla Escobar, C., Estebas Armas, C., Hervás Testal, C., Rigual Bobillo, R., Casado Fernández, L., González Martín, L., Ruiz Ares, G., Calleja Castaño, P., Carneado Ruiz, J., Fernández Ferro, J., García Pastor, A., García Torres, A., Cruz Culebras, A., Ximénez-Carrillo Rico, Á., Sobrino García, P., Oyanguren Rodeño, B., Escolar Escamilla, E., Izquierdo Esteban, L., Rodríguez Rodil, N., Martínez Gómez, J., Fuentes Gimeno, B., and Rodríguez-Pardo de Donlebún, J.

Published
2024
Full Text
View/download PDF

8. 20881. REVALIDACIÓN DE LA ESCALA M-DIRECT EN LA IDENTIFICACIÓN PREHOSPITALARIA DE PACIENTES PARA SU TRASLADO DIRECTO A HOSPITAL DE TROMBECTOMÍA MECÁNICA

Author

Rodríguez Pardo de Donlebún, J., Riera López, N., Lorente Moro, A., de Celis Ruiz, E., Alonso Castillo, R., Higuera Ruiz de la Hermosa, A., Lorenzo Diéguez, M., Gómez Escalonilla, C., Estebas Armas, C., Hervás Testal, C., Rigual Bobillo, R., Casado Fernández, L., González Martín, L., Ruiz Ares, G., Calleja Castaño, P., Carneado Ruiz, J., Fernández Ferro, J., García Pastor, A., García Torres, A., Cruz Culebras, A., Ximénez-Carrillo Rico, Á., Sobrino García, P., Oyanguren Rodeño, B., Escolar Escamilla, E., Izquierdo Esteban, L., Rodríguez Rodil, N., Martínez Gómez, J., Fuentes Gimeno, B., and Alonso de Leciñana Cases, M.

Published
2024
Full Text
View/download PDF

12. Epidemiology of Intracranial Hemorrhage Associated with Oral Anticoagulants in Spain: Trends in Anticoagulation Complications Registry - The TAC 2 Study.

Author

Zapata-Wainberg G, Quintas S, Ximénez-Carrillo Rico Á, Masjuán Vallejo J, Cardona P, Castellanos Rodrigo M, Benavente Fernández L, García Pastor A, Egido J, Maciñeiras J, Serena J, Freijo Guerrero MDM, Moniche F, and Vivancos J

Abstract

Objective: Patients receiving treatment with oral anticoagulants (OACs) are at risk of intracranial hemorrhage (ICH). In this study, we describe the epidemiological and clinical characteristics of patients receiving OACs who experience ICH and compare those receiving vitamin K antagonists (ICH-VKAs) with those receiving direct OACs (ICH-DOACs)., Methods: We performed a national, multicenter, descriptive, observational, retrospective study of all adult patients receiving OACs who were admitted to the neurology department with ICH over a 1-year period. The study population was divided into 2 groups (ICH-VKAs and ICH-DOACs). Epidemiological, clinical, radiological, and therapy-related variables, as well as functional outcome, were compared at 3 months. A total of 366 cases were included (331 ICH-VKAs, 35 ICH- DOACs)., Results: The crude annual incidence of OAC-induced ICH was 3.8 (95% CI, 2.78-3.41) per 100,000 inhabitants/year. The mean (± SD) age was greater for ICH-DOACs (81.5 ± 8.3 vs. 77.7 ± 8.3 years; p = 0.012). The median (IQR) volume of the hemorrhage was lower for ICH-DOACs (11 [30.8] vs. 25 [50.7] mL; p = 0.03). The functional independence rate at 3 months (modified Rankin Scale, mRS < 3) was similar in both groups, although stroke-related mortality was greater in ICH-VKAs (40 vs. 72.7%; p = 0.02). The most frequently indicated poststroke antithrombotic therapy was DOACs (38.7%)., Conclusion: We found that the incidence of OAC-induced ICH was greater than in previous studies. Hemorrhage volume and mortality were lower in ICH-DOACs than in ICH-VKAs. After stroke, DOACs were the most frequently indicated antithrombotic treatment.

Published
2018
Full Text
View/download PDF

13. Epidemiology of Intracranial Haemorrhages Associated with Vitamin K Antagonist Oral Anticoagulants in Spain: TAC Registry.

Author

Zapata-Wainberg G, Ximénez-Carrillo Rico Á, Benavente Fernández L, Masjuan Vallejo J, Gállego Culleré J, Freijó Guerrero Mdel M, Egido J, Gómez Sánchez JC, Martínez Domeño A, Purroy García F, Vives Pastor B, Blanco González M, and Vivancos J

Abstract

Background: Vitamin K antagonist oral anticoagulants (VKA-OACs) are effective for primary and secondary prevention of embolic events. The rate of haemorrhagic neurological complications in patients admitted to neurology departments in Spain is not yet known., Aims: We aimed to determine the clinical and epidemiological characteristics of patients with intracranial haemorrhage secondary to VKA-OACs as well as the incidence of this severe complication., Methods: We conducted a retrospective, descriptive, multi-centre study using information from the medical records of all patients admitted to neurology departments, diagnosed with spontaneous intracranial haemorrhage, and treated with VKA-OACs within a 1-year period. We collected demographic and care data from centres, patients' medical records [demographic data, medical history, haemorrhage origin, vascular risk factors, concomitant treatment, and National Institutes of Health Stroke Scale (NIHSS) scores], and patients' outcome at 3 months [independence (modified Rankin Scale score <3) and mortality rate]., Results: Twenty-one hospitals serving a population of 8,155,628 inhabitants participated in the study. The total number of cases was 235, the mean age was 78.2 (SD 9.4) years, and the baseline NIHSS score was 11.6 (SD 9.5; median 9; interquartile range 14). The VKA-OACs used were acenocoumarol in 95.3% (224 patients) and warfarin in 4.7% (11 patients). The haemorrhage origin was deep in 29.8%, lobar in 25.5%, intraventricular in 11.5%, extensive in 17.4% (>100 ml), cerebellar in 12.3%, and in the brainstem in 3.4%. The international normalised ratio was within therapeutic ranges at admission (according to indication) in 29.4% (69 patients). The global incidence (cases per 100,000 inhabitants per year) is 2.88. The in-hospital mortality rate was 40%, and 24.3% of the patients were independent at 3 months, while the mortality at 3 months was 42.6%., Conclusion: VKA-OAC treatment is associated with a large percentage of all cases of spontaneous intracranial haemorrhage, an event leading to high dependence and mortality rates.

Published
2015
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results